文献速递疼痛医学

笑气治疗复杂区域疼痛综合征的随机盲法试验

Nitrous oxide for the treatment of complex regional pain syndrome: a randomized blinded trial.
PubMed 文献 · Reg Anesth Pain Med · 2024-08-05

该随机盲法试验将44例复杂区域疼痛综合征(CRPS)患者分为笑气组(20例)和空气-氧气组(24例),笑气组接受三个隔日、每次2小时的笑气暴露。主要结局(1周和1个月疼痛评分)无显著差异,估计均数差为-0.57(95%CI:-1.42至0.28),P=0.19。结论不支持使用笑气治疗CRPS。

要点

  • 笑气暴露未显著改善CRPS患者1周和1个月的疼痛评分。
  • 次要结局包括身心健康、神经病理性疼痛症状和阿片消耗均无差异。
  • 结果不支持将笑气用于CRPS的临床治疗。

核心结论

  • 与空气-氧气相比,三个隔日、每次2小时的笑气暴露对慢性CRPS患者没有有意义的治疗潜力。

研究设计与样本

  • 随机盲法试验,共44例CRPS患者,笑气组20例,空气-氧气组24例。

主要发现

  • 疼痛评分估计均数差(笑气-空气氧气)为-0.57(95%CI:-1.42至0.28),P=0.19。
  • 身体健康Z分数估计均数差为0.13(95%CI:-0.16至0.43)。
  • 心理健康Z分数估计均数差为0.087(95%CI:-0.31至0.48)。
  • 患者整体变化印象评分估计均数差为-0.7(95%CI:-1.85至0.46)。

临床怎么用

  • 不推荐使用笑气治疗复杂区域疼痛综合征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Complex Regional Pain Syndrome (CRPS) is a debilitating neuropathic condition often refractory to conventional treatments. N-methyl-D-aspartate (NMDA) receptor antagonists have a well-established role in the development and modulation of chronic neuropathic pain. Nitrous oxide is widely used and generally safe anesthetic gas with NMDA receptor antagonist activity. We therefore tested the hypothesis that brief periods of nitrous oxide exposure reduce pain in patients with CRPS. METHODS: Patients with a diagnosis of CRPS were randomized to either 2 hours of nitrous oxide exposure on three alternating days (Nitrous Oxide) versus a placebo air/oxygen mixture (Air-Oxygen). Our primary outcome was patient-reported pain scores at 1 week and 1 month. Secondary and exploratory outcomes were physical and mental health (PRMOIS-29 v2 survey), specific neuropathic pain symptoms (McGill short-form questionnaire), and opioid consumption. RESULTS: 44 patients participated in the study; 20 were randomized to Nitrous Oxide and 24 were assigned to Air-Oxygen. Pain scores did not differ significantly, with the estimated difference in means (Nitrous Oxide-Air-Oxygen) of -0.57 (95% CI: -1.42 to 0.28) points, p=0.19. There were also no differences detected in secondary outcomes, with the estimated difference in mean Z-scores for physical health (Nitrous Oxide-Air-Oxygen) of 0.13 (95% CI: -0.16 to 0.43), mental health 0.087 (95% CI: -0.31 to 0.48), and Patient Global Impression of Change score -0.7 (95% CI: -1.85 to 0.46). CONCLUSIONS: Compared with air/oxygen, 2 hours of nitrous oxide/oxygen exposure for three sessions did not provide meaningful therapeutic potential for patients with chronic CRPS. Our results do not support using nitrous oxide for the treatment of CRPS.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Hale J, Xu J, Wang D, et al. Nitrous oxide for the treatment of complex regional pain syndrome: a randomized blinded trial. Reg Anesth Pain Med. 2024. PMID: 37898481. doi:10.1136/rapm-2023-104537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。